OBJECTIVE: HIV infection has been associated with increased cardiovascular risk. Twenty-four-hour ambulatory blood pressure (BP) is a more accurate and prognostically relevant measure of an individual's BP load than office BP, and the ambulatory BP-derived ambulatory arterial stiffness index (AASI) and symmetric AASI (s-AASI) are established cardiovascular risk factors. METHODS: In the setting of the HIV and HYpertension (HIV-HY) study, an Italian nationwide survey on high BP in HIV infection, 100 HIV-infected patients with high-normal BP or untreated hypertension (72% men, age 48 ± 10 years, BP 142/91 ± 12/7 mmHg) and 325 HIV-negative individuals with comparable age, sex distribution, and office BP (68% men, age 48 ± 10 years, BP 141/90 ± 11/8 mmHg) underwent 24-h ambulatory BP monitoring. RESULTS: Despite having similar office BP, HIV-infected individuals had higher 24-h SBP (130.6 ± 14 vs. 126.4 ± 10 mmHg) and pulse pressure (49.1 ± 9 vs. 45.9 ± 7 mmHg, both P < 0.001), and a lower day-night reduction of mean arterial pressure (14.3 ± 9 vs. 16.3 ± 7%, P = 0.025). Both s-AASI and AASI were significantly higher in HIV patients (s-AASI, 0.22 ± 0.18 vs. 0.11 ± 0.15; AASI, 0.46 ± 0.22 vs. 0.29 ± 0.17; both P <0.001). In a multivariate regression, s-AASI was independently predicted by HIV infection (β = 0.252, P <0.001), age, female sex, and 24-h SBP. In HIV patients, s-AASI had an inverse relation with CD4 cell count (Spearman's ρ -0.24, P = 0.027). CONCLUSION: Individuals with HIV infection and borderline or definite hypertension have higher symmetric AASI and 24-h systolic and pulse pressures than HIV-uninfected controls matched by office BP. High ambulatory BP may play a role in the HIV-related increase in cardiovascular risk.
OBJECTIVE:HIV infection has been associated with increased cardiovascular risk. Twenty-four-hour ambulatory blood pressure (BP) is a more accurate and prognostically relevant measure of an individual's BP load than office BP, and the ambulatory BP-derived ambulatory arterial stiffness index (AASI) and symmetric AASI (s-AASI) are established cardiovascular risk factors. METHODS: In the setting of the HIV and HYpertension (HIV-HY) study, an Italian nationwide survey on high BP in HIV infection, 100 HIV-infectedpatients with high-normal BP or untreated hypertension (72% men, age 48 ± 10 years, BP 142/91 ± 12/7 mmHg) and 325 HIV-negative individuals with comparable age, sex distribution, and office BP (68% men, age 48 ± 10 years, BP 141/90 ± 11/8 mmHg) underwent 24-h ambulatory BP monitoring. RESULTS: Despite having similar office BP, HIV-infected individuals had higher 24-h SBP (130.6 ± 14 vs. 126.4 ± 10 mmHg) and pulse pressure (49.1 ± 9 vs. 45.9 ± 7 mmHg, both P < 0.001), and a lower day-night reduction of mean arterial pressure (14.3 ± 9 vs. 16.3 ± 7%, P = 0.025). Both s-AASI and AASI were significantly higher in HIVpatients (s-AASI, 0.22 ± 0.18 vs. 0.11 ± 0.15; AASI, 0.46 ± 0.22 vs. 0.29 ± 0.17; both P <0.001). In a multivariate regression, s-AASI was independently predicted by HIV infection (β = 0.252, P <0.001), age, female sex, and 24-h SBP. In HIVpatients, s-AASI had an inverse relation with CD4 cell count (Spearman's ρ -0.24, P = 0.027). CONCLUSION: Individuals with HIV infection and borderline or definite hypertension have higher symmetric AASI and 24-h systolic and pulse pressures than HIV-uninfected controls matched by office BP. High ambulatory BP may play a role in the HIV-related increase in cardiovascular risk.
Authors: Jeroen P Kooman; Peter Kotanko; Annemie M W J Schols; Paul G Shiels; Peter Stenvinkel Journal: Nat Rev Nephrol Date: 2014-10-07 Impact factor: 28.314
Authors: Anne-Lise Paisible; Chung-Chou H Chang; Kaku A So-Armah; Adeel A Butt; David A Leaf; Matthew Budoff; David Rimland; Roger Bedimo; Matthew B Goetz; Maria C Rodriguez-Barradas; Heidi M Crane; Cynthia L Gibert; Sheldon T Brown; Hilary A Tindle; Alberta L Warner; Charles Alcorn; Melissa Skanderson; Amy C Justice; Matthew S Freiberg Journal: J Acquir Immune Defic Syndr Date: 2015-02-01 Impact factor: 3.731
Authors: Shia T Kent; Greer A Burkholder; Gabriel S Tajeu; E Turner Overton; Paul Muntner Journal: Curr Hypertens Rep Date: 2015-11 Impact factor: 5.369
Authors: Samson Okello; Stephen B Asiimwe; Michael Kanyesigye; Winnie R Muyindike; Yap Boum; Bosco B Mwebesa; Jessica E Haberer; Yong Huang; Kenneth Williams; Tricia H Burdo; Russell P Tracy; David R Bangsberg; A Rain Mocello; Jeffrey N Martin; Peter W Hunt; Mark J Siedner Journal: J Acquir Immune Defic Syndr Date: 2016-12-01 Impact factor: 3.731
Authors: John E Lewis; Jillian Poles; Eleanor Garretson; Eduard Tiozzo; Sharon Goldberg; Carmen S G Campbell; Herbert G Simões; Judi M Woolger; Janet Konefal Journal: Am J Lifestyle Med Date: 2020-02-11
Authors: Mark J Siedner; June-Ho Kim; Ruth Sentongo Nakku; Linda Hemphill; Virginia A Triant; Jessica E Haberer; Jeffrey N Martin; Yap Boum; Douglas S Kwon; Alexander C Tsai; Peter W Hunt; Samson Okello; David R Bangsberg Journal: AIDS Date: 2016-02-20 Impact factor: 4.177
Authors: Giuseppe Vittorio De Socio; Elena Ricci; Giustino Parruti; Leonardo Calza; Paolo Maggi; Benedetto Maurizio Celesia; Giancarlo Orofino; Giordano Madeddu; Canio Martinelli; Barbara Menzaghi; Lucia Taramasso; Giovanni Penco; Laura Carenzi; Marco Franzetti; Paolo Bonfanti Journal: Infection Date: 2016-04-05 Impact factor: 3.553
Authors: Shia T Kent; Samantha G Bromfield; Greer A Burkholder; Louise Falzon; Suzanne Oparil; Edgar T Overton; Michael J Mugavero; Joseph E Schwartz; Daichi Shimbo; Paul Muntner Journal: PLoS One Date: 2016-02-16 Impact factor: 3.240
Authors: Jes M Sanders; Alexandra B Steverson; Anna E Pawlowski; Daniel Schneider; Chad J Achenbach; Donald M Lloyd-Jones; Matthew J Feinstein Journal: PLoS One Date: 2018-03-20 Impact factor: 3.240